Actinia equina Extract Coating Prevents Biofilm Adhesion
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Biofilms pose a significant challenge due to their resistance to antibiotics and difficulty in elimination, leading to persistent infections and biofouling issues in medical devices and industrial systems, with existing solutions being inadequate in preventing adhesion and formation effectively.
Innovation Solution
A composition derived from Actinia equina, including polar extracts and polypeptides like equinatoxin, is used to prevent bacterial adhesion to surfaces, inhibiting biofilm formation without cytotoxic effects, and can be applied as a coating for medical devices or used in water treatment to reduce biofouling.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If antibiotics are used to treat biofilm infections, then bacterial growth is inhibited, but the treatment becomes ineffective against attached biofilm microorganisms
Solution Approach 1:
The patent applies preliminary action by preventing biofilm formation in the first place through antimicrobial coatings on medical devices. By coating the device surface with antimicrobial agents before implantation, the bacteria are prevented from attaching and forming biofilms, thus eliminating the need for subsequent antibiotic treatment against resistant biofilm infections.
2Object-affected harmful factors
If medical devices are coated with traditional antimicrobial agents, then bacterial adhesion is reduced, but cytotoxic effects occur on surrounding tissues
Solution Approach 1:
The patent applies parameter changes by modifying the concentration and composition of antimicrobial peptides in the coating formulation. Specifically, the patent uses lower concentrations of antimicrobial peptides and combines them with other compounds to achieve effective bacterial adhesion prevention while reducing cytotoxic effects on surrounding mammalian cells.
Solution Approach 2:
The patent applies composite materials by creating a coating formulation that combines multiple antimicrobial peptides with different properties and concentrations. This composite approach allows the coating to maintain effective antimicrobial activity while reducing individual peptide cytotoxicity through synergistic effects and balanced composition.
3Reliability
If devices are made antimicrobial to prevent infection, then biofilm formation is reduced, but device complexity and manufacturing difficulty increase
Solution Approach 1:
The patent applies this principle by using a coating formulation that can be applied during the manufacturing process and provides sufficient protection for the intended device lifespan. The coating is designed to be cost-effective and simple to apply, avoiding complex multi-layer systems or expensive application equipment, thus maintaining device simplicity while providing infection prevention.
Data Source
Figure 1A~1B
Figure 2
Figure 3A~3D
AI summary
A composition comprising an extract from an aquatic organism is disclosed. The composition is capable of preventing adhesion of a cell to a surface and is devoid of cytotoxic or cytostatic activity. Medical devices comprising same and methods for preventing or treating a pathological infection using same are also disclosed.